Incyte (INCY) Other Accumulated Expenses (2009 - 2026)
Incyte's Other Accumulated Expenses came in at $209.5 million for Q2 2022, up 64.7% from $127.22 million a year earlier and up 21.8% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Other Accumulated Expenses (2009 - 2026) Analysis & Trends
At the end of FY2021, Incyte's Other Accumulated Expenses was $168.41 million, up 58.9% from FY2020.
- Other Accumulated Expenses has increased in each of the last four years, with a four-year compound annual growth rate of 64.8% (FY2017 to FY2021).
- Going back by year, Other Accumulated Expenses was $106.01 million in FY2020 (+44.8%), $73.22 million in FY2019 (+111.8%), $34.57 million in FY2018 (+51.6%) and $22.81 million in FY2017.
- The Q2 2022 figure represents the highest quarterly Other Accumulated Expenses in data going back to Q4 2017.
- Year-over-year, Other Accumulated Expenses has increased for seven consecutive quarters, with growth averaging 56.2% over the last seven quarters.
- Across the past five years, year-over-year growth in Other Accumulated Expenses ran from 44.8% in Q4 2020 to 111.8% in Q4 2019.
- Business Quant data shows INCY's Other Accumulated Expenses at $171.96 million (Q1 2022), $168.41 million (Q4 2021) and $142.45 million (Q3 2021) in the three quarters before Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 190.99 Mn |
| Jun 30, 2026 | 148.32 Mn |
| Mar 31, 2026 | 124.92 Mn |
| Dec 31, 2025 | 228.07 Mn |
| Sep 30, 2025 | 168.25 Mn |
| Jun 30, 2025 | 129.11 Mn |
| Mar 31, 2025 | 102.82 Mn |
| Dec 31, 2024 | 188.68 Mn |
| Sep 30, 2024 | 150.72 Mn |
| Jun 30, 2024 | 113.54 Mn |
| Mar 31, 2024 | 89.11 Mn |
| Dec 31, 2023 | 153.35 Mn |
| Sep 30, 2023 | 124.78 Mn |
| Jun 30, 2023 | 111.71 Mn |
| Mar 31, 2023 | 84.72 Mn |
| Dec 31, 2022 | 138.76 Mn |
| Sep 30, 2022 | 106.31 Mn |
| Jun 30, 2022 | 209.50 Mn |
| Mar 31, 2022 | 171.96 Mn |
| Dec 31, 2021 | 168.41 Mn |
API Access
Incyte Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();